中文名稱:維西珠單抗 | 英文名稱:Research Grade Visilizumab |
CAS:219716-33-3 | 純度規(guī)格: 95% PAGE |
產品類別: 藥物對照抗體 | |
抗體名: Research Grade Visilizumab | 靶點: CD3e, CD3E |
宿主: Humanized | 適應物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Research Grade Visilizumab |
Catalog No.
DHC27704
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG2-nd
Applications
Research Grade Biosimilar
Target
T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P07766
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
HuM291, CAS: 219716-33-3
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 700萬 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術服務 | 經營模式 | 試劑 |
產品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥50000 |
VIP5年
|
武漢維斯爾曼生物工程有限公司
|
2025-02-12 | |
¥3850 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2025-02-11 | |
詢價 |
VIP1年
|
湖南瑞威爾生物科技有限公司
|
2025-02-14 |